arrow
A

Alberto Mateo-Urdiales

Istituto Superiore di Sanità
H指数:25
被引数:2,637

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Effectiveness of Influenza Vaccines in Italy in the 2024/2025 Season: A Nationwide, Test-Negative Design Study Based on Surveillance Records

2024/2025流感季意大利流感疫苗有效性:一项基于监测记录的全国性、测试阴性设计研究

2026-04-300
OAAI
Unmeasured confounding and misclassification in studies estimating vaccine effectiveness against hospitalisation and death using electronic health records (EHRs): an evaluation of a multi-country European retrospective cohort study

未测量混杂和错分偏倚在利用电子健康记录(EHRs)评估疫苗对住院和死亡的保护效果研究中的影响:一项多国欧洲回顾性队列研究的评估

2025-12-170
OAAI
Effectiveness of JN.1 monovalent COVID-19 vaccination in EU/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network study

JN.1单价COVID-19疫苗接种在欧盟/欧洲经济区国家(2024年10月至2025年1月)的有效性:一项VEBIS电子健康记录网络研究

Vaccine
IF3.5
2025-09-190
PRE
Collaborative forecasting of influenza-like illness in Italy: The Influcast experience

意大利流感样疾病的协作预测: 经验

2025-03-010
OA
Case-time series study on the short-term impact of meteorological factors on West Nile Virus incidence in Italy at the local administrative unit level, 2012 to 2021
2025-01-010
OAAI
Risk of breakthrough infection and hospitalisation after COVID-19 primary vaccination by HIV status in four Italian regions during 2021
2024-06-110
OAAI
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network Study

10月2023年11月,XBB.1.5单价新型冠状病毒肺炎疫苗在欧盟/欧洲经济区国家XBB.1.5主导时期的有效性: vebis-ehr网络研究

2024-04-233
OA
Socioeconomic Inequalities in SARS-CoV-2 Infection and COVID-19 Health Outcomes in Urban Italy During the COVID-19 Vaccine Rollout, January-November 2021

2021年1月到11月新型冠状病毒肺炎疫苗推广期间意大利城市SARS-CoV-2感染和新型冠状病毒肺炎健康结果的社会经济不平等

2024-03-181
OAAI
Effect of an enhanced public health contact tracing intervention on the secondary transmission of SARS-CoV-2 in educational settings: The four-way decomposition analysis

加强公共卫生接触者追踪干预对教育环境中SARS-CoV-2二次传播的影响: 四向分解分析

2024-02-280
OA
Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023

≥ 65岁人群新型冠状病毒肺炎住院的相对疫苗有效性: 欧洲VEBIS网络的结果,2021年10月2023年7月

2024-01-041
OAAI
Relative effectiveness of monovalent and bivalent mRNA boosters in preventing severe COVID-19 due to omicron BA.5 infection up to 4 months post-administration in people aged 60 years or older in Italy: a retrospective matched cohort study
2023-12-0123
OAAI
Estimating SARS-CoV-2 infections and associated changes in COVID-19 severity and fatality

估计SARS-CoV-2感染以及新型冠状病毒肺炎严重程度和死亡率的相关变化

2023-08-1614
OA